The sterile immune response during hepatic ischemia/reperfusion

Cytokine and Growth Factor Reviews

Volumn 23, Issue 3, 2012, Pages 69-84

  van Golen, Rowan F ^a   van Gulik, Thomas M ^a   Heger, Michal ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Damage associated molecular patterns; Innate immunity and sterile inflammation; Liver surgery and transplantation; Microcirculation; Oxidative and nitrosative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD11B ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CELL NUCLEUS DNA; CELL SURFACE RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE; INTERCELLULAR ADHESION MOLECULE 1; KIDNEY INJURY MOLECULE 1; MITOCHONDRIAL DAMAGE ASSOCIATED MOLECULAR PATTERN PROTEIN; MITOCHONDRIAL PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; URATE;

BIOCHEMISTRY; CD4+ T LYMPHOCYTE; CELL INTERACTION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOWN REGULATION; GAMMA DELTA T LYMPHOCYTE; HEPATITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; LEUKOCYTE ADHERENCE; LIVER ISCHEMIA; LYMPHOCYTE MIGRATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ADENOSINE TRIPHOSPHATE; DENDRITIC CELLS; DNA; HEPATITIS; HEPATOCYTES; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; KUPFFER CELLS; LIVER; LIVER DISEASES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SURGICAL PROCEDURES, OPERATIVE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; URIC ACID;

EID: 84861661391     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2012.04.006     Document Type: Review

References (185)

1. Janeway C.A., Carding S., Jones B., Murray J., Portoles P., Rasmussen R., et al. CD4+ T cells: specificity and function. Immunological Reviews 1988, 101(January):39-80.
2. Matzinger P. Tolerance, danger, and the extended family. Annual Review of Immunology 1994, 12:991-1045.
3. Teoh N.C., Farrell G.C. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. Journal of Gastroenterology and Hepatology 2003, 18(August (8)):891-902.
4. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. American Journal of Physiology: Gastrointestinal and Liver Physiology 2006, 290(June (6)):G1083-G1088.
5. Shen X., Wang Y., Gao F., Ren F., Busuttil R.W., Kupiec-Weglinski J.W., et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009, 50(November (5)):1537-1546.
6. Nathan C. Neutrophils and immunity: challenges and opportunities. Nature Reviews: Immunology 2006, 6(March (3)):173-182.
7. van Golen R.F., van Gulik T.M., Heger M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radical Biology & Medicine 2012, 52(January (8)):1382-1402.
8. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nature Reviews: Immunology 2008, 8(April (4)):279-289.
9. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nature Reviews: Immunology 2010, 10(December (12)):826-837.
10. 2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 1987, 325(6099):78-81.
11. i, and cytotoxicity in rat hepatocytes. The Journal of Biological Chemistry 1992, 267(April (10)):6654-6663.
12. Tsung A., Klune J.R., Zhang X., Jeyabalan G., Cao Z., Peng X., et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. The Journal of Experimental Medicine 2007, 204(November (12)):2913-2923.
13. Gujral J.S., Bucci T.J., Farhood A., Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 2001, 33(February (2)):397-405.
14. Bhogal R.H., Curbishley S.M., Weston C.J., Adams D.H., Afford S.C. Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transplantation 2010, 16(November (11)):1303-1313.
15. McDonald B., Kubes P. Neutrophils and intravascular immunity in the liver during infection and sterile inflammation. Toxicologic Pathology 2011, 40(November (2)):157-165.
16. Kuboki S., Sakai N., Tschöp J., Edwards M.J., Lentsch A.B., Caldwell C.C. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury. American Journal of Physiology: Gastrointestinal and Liver Physiology 2009, 296(May (5)):G1054-G1059.
17. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311(January (5757)):83-87.
18. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nature Reviews: Immunology 2010, 10(November (11)):753-766.
19. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327(February (5966)):656-661.
20. Meylan E., Tschopp J., Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006, 442(July (7098)):39-44.
21. Akira S., Takeda K. Toll-like receptor signalling. Nature Reviews: Immunology 2004, 4(July (7)):499-511.
22. Bamboat Z.M., Ocuin L.M., Balachandran V.P., Obaid H., Plitas G., Dematteo R.P. Conventional dcs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. The Journal of Clinical Investigation 2010, 120(January (2)):559-569.
23. Liu W., Hou Y., Chen H., Wei H., Lin W., Li J., et al. Sample preparation method for isolation of single-cell types from mouse liver for proteomic studies. Proteomics 2011, 11(September (17)):3556-3564.
24. Plitas G., Burt B.M., Stableford J.A., Nguyen H.M., Welles A.P., DeMatteo R.P. Dendritic cells are required for effective cross-presentation in the murine liver. Hepatology 2008, 47(April (4)):1343-1351.
25. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nature Reviews: Immunology 2008, 8(December (12)):958-969.
26. McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., Waterhouse C.C., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330(October (6002)):362-366.
27. Khandoga A., Hanschen M., Kessler J.S., Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 2006, 43(February (2)):306-315.
28. Nathan C.F. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. The Journal of Clinical Investigation 1987, 80(December (6)):1550-1560.
29. Savina A., Jancic C., Hugues S., Guermonprez P., Vargas P., Moura I.C., et al. NOX2 controls phagosomal ph to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006, 126(1):205-218.
30. Turrens J.F. Mitochondrial formation of reactive oxygen species. The Journal of Physiology 2003, 552(October (Pt 2)):335-344.
31. Klebanoff S.J. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 2005, 77(May (5)):598-625.
32. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' dna-binding proteins. Trends in Biochemical Sciences 2001, 26(March (3)):167-174.
33. Bell C.W., Jiang W., Reich C.F., Pisetsky D.S. The extracellular release of HMGB1 during apoptotic cell death. American Journal of Physiology: Cell Physiology 2006, 291(December (6)):C1318-C1325.
34. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418(July (6894)):191-195.
35. Evankovich J., Cho S.W., Zhang R., Cardinal J., Dhupar R., Zhang L., et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. The Journal of Biological Chemistry 2010, 285(October (51)):39888-39897.
36. Dhupar R., Klune J.R., Evankovich J., Cardinal J., Zhang M., Ross M., et al. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock 2011, 35(March (3)):293-301.
37. Tsung A., Stang M.T., Ikeda A., Critchlow N.D., Izuishi K., Nakao A., et al. The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. American Journal of Physiology: Gastrointestinal and Liver Physiology 2006, 290(June (6)):G1261-G1268.
38. Dornan D., Eckert M., Wallace M., Shimizu H., Ramsay E., Hupp T.R., et al. Interferon regulatory factor 1 binding to p300 stimulates dna-dependent acetylation of p53. Molecular and Cellular Biology 2004, 24(November (22)):10083-10098.
39. Doyle K., Fitzpatrick F.A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. The Journal of Biological Chemistry 2010, 285(June (23)):17417-17424.
40. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. The EMBO Journal 2003, 22(October (20)):5551-5560.
41. Zhang X., Guo L., Collage R.D., Stripay J.L., Tsung A., Lee J.S., et al. Calcium/calmodulin-dependent protein kinase (camk) ialpha mediates the macrophage inflammatory response to sepsis. Journal of Leukocyte Biology 2011, 90(August (2)):249-261.
42. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29(July (1)):21-32.
43. Antoine D.J., Williams D.P., Kipar A., Laverty H., Park B.K. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Molecular Medicine 2010, 16(11-12):479-490.
44. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., et al. A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(June (26)):11942-11947.
45. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. The Journal of Experimental Medicine 2005, 201(April (7)):1135-1143.
46. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. Journal of Immunology 2005, 174(June (12)):7506-7515.
47. Su G.L., Klein R.D., Aminlari A., Zhang H.Y., Steinstraesser L., Alarcon W.H., et al. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 2000, 31(April (4)):932-936.
48. Broering R., Wu J., Meng Z., Hilgard P., Lu M., Trippler M., et al. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. Journal of Hepatology 2008, 48(June (6)):914-922.
49. Powers K.A., Szászi K., Khadaroo R.G., Tawadros P.S., Marshall J.C., Kapus A., et al. Oxidative stress generated by hemorrhagic shock recruits toll-like receptor 4 to the plasma membrane in macrophages. The Journal of Experimental Medicine 2006, 203(August (8)):1951-1961.
50. Zhai Y., Shen X.D., O'Connell R., Gao F., Lassman C., Busuttil R.W., et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent myd88-independent pathway. Journal of Immunology 2004, 173(December (12)):7115-7119.
51. Zhai Y., Qiao B., Gao F., Shen X., Vardanian A., Busuttil R.W., et al. but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 2008, 47(January (1)):199-206.
52. Taniguchi T., Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nature Reviews: Molecular Cell Biology 2001, 2(May (5)):378-386.
53. Zhai Y., Shen X.D., Gao F., Zhao A., Freitas M.C., Lassman C., et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008, 47(January (1)):207-214.
54. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., et al. TLR4, but not TLR2, mediates ifn-beta-induced stat1alpha/beta-dependent gene expression in macrophages. Nature Immunology 2002, 3(April (4)):392-398.
55. Yamamoto Y., Harashima A., Saito H., Tsuneyama K., Munesue S., Motoyoshi S., et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. Journal of Immunology 2011, 186(March (5)):3248-3257.
56. Zeng S., Dun H., Ippagunta N., Rosario R., Zhang Q.Y., Lefkowitch J., et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. Journal of Hepatology 2009, 50(May (5)):929-936.
57. Zeng S., Feirt N., Goldstein M., Guarrera J., Ippagunta N., Ekong U., et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004, 39(February (2)):422-432.
58. Uehara T., Bennett B., Sakata S.T., Satoh Y., Bilter G.K., Westwick J.K., et al. JNK mediates hepatic ischemia reperfusion injury. Journal of Hepatology 2005, 42(June (6)):850-859.
59. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Medicine 2000, 6(December (12)):1355-1361.
60. Guimarães E.L., Empsen C., Geerts A., van Grunsven L.A. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. Journal of Hepatology 2010, 52(March (3)):389-397.
61. 2- generation by mononuclear phagocytes in diabetes. Journal of Leukocyte Biology 2007, 81(February (2)):520-527.
62. Ishii K.J., Suzuki K., Coban C., Takeshita F., Itoh Y., Matoba H., et al. Genomic DNA released by dying cells induces the maturation of apcs. Journal of Immunology 2001, 167(September (5)):2602-2607.
63. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408(December (6813)):740-745.
64. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. The Journal of Experimental Medicine 2001, 194(September (6)):863-869.
65. Tsuda Y., Takahashi H., Kobayashi M., Hanafusa T., Herndon D.N., Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004, 21(August (2)):215-226.
66. Swartz M.N., Trautner T.A., Kornberg A. Enzymatic synthesis of deoxyribonucleic acid. XI. Further studies on nearest neighbor base sequences in deoxyribonucleic acids. The Journal of Biological Chemistry 1962, 237(June):1961-1967.
67. Sano H., Takai O., Harata N., Yoshinaga K., Kodama-Kamada I., Sasaki T. Binding properties of human anti-dna antibodies to cloned human DNA fragments. Scandinavian Journal of Immunology 1989, 30(July (1)):51-63.
68. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., Möröy T. Features of systemic lupus erythematosus in dnase1-deficient mice. Nature Genetics 2000, 25(June (2)):177-181.
69. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-Like receptor 9-dependent activation by dna-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunology 2007, 8(May (5)):487-496.
70. Ivanov S., Dragoi A.M., Wang X., Dallacosta C., Louten J., Musco G., et al. A novel role for HMGB1 in tlr9-mediated inflammatory responses to cpg-dna. Blood 2007, 110(September (6)):1970-1981.
71. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to cpg DNA in the lysosome. Nature Immunology 2004, 5(February (2)):190-198.
72. Ewald S.E., Lee B.L., Lau L., Wickliffe K.E., Shi G.P., Chapman H.A., et al. The ectodomain of toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008, 456(December (7222)):658-662.
73. Klinman D.M. Immunotherapeutic uses of cpg oligodeoxynucleotides. Nature Reviews: Immunology 2004, 4(April (4)):249-258.
74. Bamboat Z.M., Balachandran V.P., Ocuin L.M., Obaid H., Plitas G., Dematteo R.P. Toll-Like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2009, 51(October (2)):621-632.
75. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory cpg motifs. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(October (21)):12631-12636.
76. Ke B., Shen X.D., Tsuchihashi S., Gao F., Araujo J.A., Busuttil R.W., et al. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity. Human Gene Therapy 2007, 18(April (4)):355-366.
77. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature Immunology 2006, 7(March (3)):311-317.
78. Yamaguchi Y., Matsumura F., Takeya M., Ichiguchi O., Kuratsu J.I., Horiuchi T., et al. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology 1998, 27(March (3)):727-734.
79. Frink M., Hsieh Y.C., Thobe B.M., Choudhry M.A., Schwacha M.G., Bland K.I., et al. TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following trauma-hemorrhage. Molecular Immunology 2007, 44(April (10)):2625-2630.
80. Narni-Mancinelli E., Campisi L., Bassand D., Cazareth J., Gounon P., Glaichenhaus N., et al. Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes. The Journal of Experimental Medicine 2007, 204(September (9)):2075-2087.
81. Auffray C., Fogg D.K., Narni-Mancinelli E., Senechal B., Trouillet C., Saederup N., et al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. The Journal of Experimental Medicine 2009, 206(March (3)):595-606.
82. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011, 34(February (2)):213-223.
83. Yoshidome H., Kato A., Edwards M.J., Lentsch A.B. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappab. Hepatology 1999, 30(July (1)):203-208.
84. Xu J., Zhang X., Pelayo R., Monestier M., Ammollo C.T., Semeraro F., et al. Extracellular histones are major mediators of death in sepsis. Nature Medicine 2009, 15(November (11)):1318-1321.
85. Huang H., Evankovich J., Yan W., Nace G., Zhang L., Ross M., et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through toll-like receptor 9. Hepatology 2011, 54(June (3)):999-1008.
86. Jaeschke H., Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003, 125(October (4)):1246-1257.
87. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial damps cause inflammatory responses to injury. Nature 2010, 464(March (7285)):104-107.
88. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Immunology 2010, 11(February (2)):136-140.
89. Le Y., Oppenheim J.J., Wang J.M. Pleiotropic roles of formyl peptide receptors. Cytokine & Growth Factor Reviews 2001, 12(March (1)):91-105.
90. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461(September (7261)):282-286.
91. da Silva C.G., Specht A., Wegiel B., Ferran C., Kaczmarek E. Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 2009, 119(February (6)):871-879.
92. Ding Y., Gao Z.G., Jacobson K.A., Suffredini A.F. Dexamethasone enhances atp-induced inflammatory responses in endothelial cells. The Journal of Pharmacology and Experimental Therapeutics 2010, 335(December (3)):693-702.
93. Xiang Z., Lv J., Jiang P., Chen C., Jiang B., Burnstock G. Expression of P2X receptors on immune cells in the rat liver during postnatal development. Histochemistry and Cell Biology 2006, 126(October (4)):453-463.
94. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469(January (7329)):221-225.
95. + channels are redox-sensitive pathways that control reactive oxygen species production. Free Radical Biology & Medicine 2007, 42(April (7)):1039-1048.
96. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nature Reviews: Immunology 2010, 10(March (3)):210-215.
97. Agostini L., Martinon F., Burns K., McDermott M.F., Hawkins P.N., Tschopp J. NALP3 forms an il-1beta-processing inflammasome with increased activity in muckle-wells autoinflammatory disorder. Immunity 2004, 20(March (3)):319-325.
98. Meissner F., Molawi K., Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nature Immunology 2008, 9(August (8)):866-872.
99. Martinez I., Sveinbjørnsson B., Vidal-Vanaclocha F., Asumendi A., Smedsrød B. Differential cytokine-mediated modulation of endocytosis in rat liver endothelial cells. Biochemical and Biophysical Research Communications 1995, 212(July (1)):235-241.
100. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nature Reviews: Immunology 2007, 7(October (10)):803-815.
101. Khandoga A., Biberthaler P., Enders G., Axmann S., Hutter J., Messmer K., et al. Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 2002, 74(September (5)):681-688.
102. Sindram D., Porte R.J., Hoffman M.R., Bentley R.C., Clavien P.A. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000, 118(January (1)):183-191.
103. Gonzales E., Julien B., Serrière-Lanneau V., Nicou A., Doignon I., Lagoudakis L., et al. ATP release after partial hepatectomy regulates liver regeneration in the rat. Journal of Hepatology 2010, 52(January (1)):54-62.
104. Pardo M., Budick-Harmelin N., Tirosh B., Tirosh O. Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules. Free Radical Biology & Medicine 2008, 45(October (8)):1073-1083.
105. Zhu P., Duan L., Chen J., Xiong A., Xu Q., Zhang H., et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice. Human Gene Therapy 2011, 22(March (7)):853-864.
106. Dinarello C.A. Anti-Inflammatory agents: present and future. Cell 2010, 140(March (6)):935-950.
107. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425(October (6957)):516-521.
108. Kono H., Chen C.J., Ontiveros F., Rock K.L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. The Journal of Clinical Investigation 2010, 120(June (6)):1939-1949.
109. Pesonen E.J., Linder N., Raivio K.O., Sarnesto A., Lapatto R., Höckerstedt K., et al. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 1998, 114(May (5)):1009-1015.
110. Layton M.E., Wood J.G., Yan Z.Y., Forster J. Ischemia/reperfusion alters uric acid and ascorbic acid levels in liver. The Journal of Surgical Research 1996, 64(July (1)):1-5.
111. Ng G., Sharma K., Ward S.M., Desrosiers M.D., Stephens L.A., Schoel W.M., et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and syk kinase activation in dendritic cells. Immunity 2008, 29(November (5)):807-818.
112. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology 2008, 9(August (8)):847-856.
113. Liu-Bryan R., Scott P., Sydlaske A., Rose D.M., Terkeltaub R. Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis and Rheumatism 2005, 52(September (9)):2936-2946.
114. Zwacka R.M., Zhang Y., Halldorson J., Schlossberg H., Dudus L., Engelhardt J.F. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. The Journal of Clinical Investigation 1997, 100(July (2)):279-289.
115. Uchida Y., Ke B., Freitas M.C., Ji H., Zhao D., Benjamin E.R., et al. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 2010, 51(April (4)):1363-1372.
116. Uchida Y., Ke B., Freitas M.C., Yagita H., Akiba H., Busuttil R.W., et al. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a tlr4-dependent manner. Gastroenterology 2010, 139(July (6)):2195-2206.
117. Hayday A., Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nature Reviews: Immunology 2003, 3(March (3)):233-242.
118. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: what's in a name?. Nature Reviews: Immunology 2004, 4(March (3)):231-237.
119. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nature Immunology 2002, 3(December (12)):1129-1134.
120. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., Spriggs M.K. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. The Journal of Experimental Medicine 1993, 178(August (2)):669-674.
121. Suttles J., Stout R.D. Macrophage CD40 signaling: a pivotal regulator of disease protection and pathogenesis. Seminars in Immunology 2009, 21(October (5)):257-264.
122. van Kooten C., Banchereau J. CD40-CD40 ligand. Journal of Leukocyte Biology 2000, 67(January (1)):2-17.
123. Mukundan L., Bishop G.A., Head K.Z., Zhang L., Wahl L.M., Suttles J. TNF receptor-associated factor 6 is an essential mediator of cd40-activated proinflammatory pathways in monocytes and macrophages. Journal of Immunology 2005, 174(January (2)):1081-1090.
124. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. Journal of Immunology 1995, 155(November (10)):4917-4925.
125. Kornbluth R.S., Kee K., Richman D.D. CD40 ligand (CD154) stimulation of macrophages to produce hiv-1-suppressive beta-chemokines. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(April (9)):5205-5210.
126. Tian L., Noelle R.J., Lawrence D.A. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. European Journal of Immunology 1995, 25(January (1)):306-309.
127. Mathur R.K., Awasthi A., Wadhone P., Ramanamurthy B., Saha B. Reciprocal CD40 signals through p38mapk and ERK-1/2 induce counteracting immune responses. Nature Medicine 2004, 10(May (5)):540-544.
128. Kojima N., Sato M., Suzuki A., Sato T., Satoh S., Kato T., et al. Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver. Hepatology 2001, 34(October (4 Pt 1)):751-757.
129. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annual Review of Immunology 2005, 23:515-548.
130. Frauwirth K.A., Thompson C.B. Activation and inhibition of lymphocytes by costimulation. The Journal of Clinical Investigation 2002, 109(February (3)):295-299.
131. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., et al. Modulation of tcr-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(September (18)):11790-11795.
132. Decker E.L., Nehmann N., Kampen E., Eibel H., Zipfel P.F., Skerka C. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Research 2003, 31(3):911-921.
133. Li-Weber M., Laur O., Krammer P.H. Novel egr/NF-AT composite sites mediate activation of the CD95 (APO-1/fas) ligand promoter in response to T cell stimulation. European Journal of Immunology 1999, 29(September (9)):3017-3027.
134. Nakajima H., Mizuta N., Fujiwara I., Sakaguchi K., Ogata H., Magae J., et al. Blockade of the fas/fas ligand interaction suppresses hepatocyte apoptosis in ischemia-reperfusion rat liver. Apoptosis 2008, 13(August (8)):1013-1021.
135. Kuchroo V.K., Dardalhon V., Xiao S., Anderson A.C. New roles for TIM family members in immune regulation. Nature Reviews: Immunology 2008, 8(August (8)):577-580.
136. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., et al. Th1-specific cell surface protein tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415(January (6871)):536-541.
137. Hirashima M., Kashio Y., Nishi N., Yamauchi A., Imaizumi T.A., Kageshita T., et al. Galectin-9 in physiological and pathological conditions. Glycoconjugate Journal 2004, 19(7-9):593-600.
138. Khandoga A., Biberthaler P., Messmer K., Krombach F. Platelet-Endothelial cell interactions during hepatic ischemia-reperfusion in vivo: a systematic analysis. Microvascular Research 2003, 65(March (2)):71-77.
139. Danese S., de la Motte C., Reyes B.M., Sans M., Levine A.D., Fiocchi C. Cutting edge: T cells trigger cd40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. Journal of Immunology 2004, 172(February (4)):2011-2015.
140. Wagers A.J., Waters C.M., Stoolman L.M., Kansas G.S. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on alpha1, 3-fucosyltransferase VII gene expression. The Journal of Experimental Medicine 1998, 188(December (12)):2225-2231.
141. Lentsch A.B., Yoshidome H., Kato A., Warner R.L., Cheadle W.G., Ward P.A., et al. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999, 30(December (6)):1448-1453.
142. Hammond K.J., Pellicci D.G., Poulton L.D., Naidenko O.V., Scalzo A.A., Baxter A.G., et al. Cd1D-restricted NKT cells: an interstrain comparison. Journal of Immunology 2001, 167(August (3)):1164-1173.
143. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse cd1-specific NK1 T cells: development, specificity, and function. Annual Review of Immunology 1997, 15:535-562.
144. Brozovic S., Nagaishi T., Yoshida M., Betz S., Salas A., Chen D., et al. Cd1D function is regulated by microsomal triglyceride transfer protein. Nature Medicine 2004, 10(May (5)):535-539.
145. Lee W.Y., Moriarty T.J., Wong C.H., Zhou H., Strieter R.M., van Rooijen N., et al. An intravascular immune response to borrelia burgdorferi involves Kupffer cells and inkt cells. Nature Immunology 2010, 11(April (4)):295-302.
146. Tatsumi T., Takehara T., Yamaguchi S., Sasakawa A., Yamamoto M., Fujita Y., et al. Decreased expressions of cd1d molecule on liver dendritic cells in subcutaneous tumor bearing mice. Journal of Hepatology 2008, 49(November (5)):779-786.
147. Lappas C.M., Day Y.J., Marshall M.A., Engelhard V.H., Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting cd1d-dependent NKT cell activation. The Journal of Experimental Medicine 2006, 203(November (12)):2639-2648.
148. Beldi G., Banz Y., Kroemer A., Sun X., Wu Y., Graubardt N., et al. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology 2010, 51(May (5)):1702-1711.
149. Vilcek J. Novel interferons. Nature Immunology 2003, 4(January (1)):8-9.
150. Jaruga B., Hong F., Kim W.H., Gao B. Ifn-Gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. American Journal of Physiology: Gastrointestinal and Liver Physiology 2004, 287(November (5)):G1044-G1052.
151. Watanabe Y., Suzuki O., Haruyama T., Akaike T. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. Journal of Cellular Biochemistry 2003, 89(May (2)):244-253.
152. Caldwell C.C., Okaya T., Martignoni A., Husted T., Schuster R., Lentsch A.B. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. American Journal of Physiology: Gastrointestinal and Liver Physiology 2005, 289(November (5)):G969-G976.
153. Bonneville M., O'Brien R.L., Born W.K. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nature Reviews: Immunology 2010, 10(July (7)):467-478.
154. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. The Journal of Biological Chemistry 2003, 278(January (3)):1910-1914.
155. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22(March (3)):285-294.
156. Husted T.L., Blanchard J., Schuster R., Shen H., Lentsch A.B. Potential role for IL-23 in hepatic ischemia/reperfusion injury. Inflammation Research 2006, 55(May (5)):177-178.
157. Kono H., Fujii H., Ogiku M., Hosomura N., Amemiya H., Tsuchiya M., et al. Role of IL-17A in neutrophil recruitment and hepatic injury after warm ischemia-reperfusion mice. Journal of Immunology 2011, 187(November (9)):4818-4825.
158. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., et al. Differential roles of interleukin-17a and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30(January (1)):108-119.
159. de Boer O.J., van der Meer J.J., Teeling P., van der Loos C.M., Idu M.M., van Maldegem F., et al. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. The Journal of Pathology 2010, 220(March (4)):499-508.
160. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nature Reviews: Immunology 2009, 9(August (8)):556-567.
161. Anderson P. Post-transcriptional control of cytokine production. Nature Immunology 2008, 9(April (4)):353-359.
162. + T cells. Nature Reviews: Immunology 2011, 11(October (10)):645-657.
163. Junger W.G. Immune cell regulation by autocrine purinergic signalling. Nature Reviews: Immunology 2011, 11(March (3)):201-212.
164. McDonald B., Kubes P. Chemokines: sirens of neutrophil recruitment-but is it just one song?. Immunity 2010, 33(August (2)):148-149.
165. Sadik C.D., Kim N.D., Luster A.D. Neutrophils cascading their way to inflammation. Trends in Immunology 2011, 32(October (10)):452-460.
166. Eash K.J., Greenbaum A.M., Gopalan P.K., Link D.C. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. The Journal of Clinical Investigation 2010, 120(July (7)):2423-2431.
167. Uchida Y., Freitas M.C., Zhao D., Busuttil R.W., Kupiec-Weglinski J.W. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transplantation 2009, 15(August (8)):939-947.
168. Lentsch A.B., Yoshidome H., Cheadle W.G., Miller F.N., Edwards M.J. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998, 27(April (4)):1172-1177.
169. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Reviews: Immunology 2007, 7(September (9)):678-689.
170. Wong J., Johnston B., Lee S.S., Bullard D.C., Smith C.W., Beaudet A.L., et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. The Journal of Clinical Investigation 1997, 99(June (11)):2782-2790.
171. Horie Y., Wolf R., Anderson D.C., Granger D.N. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. The Journal of Clinical Investigation 1997, 99(February (4)):781-788.
172. Heit B., Colarusso P., Kubes P. Fundamentally different roles for LFA-1, mac-1 and alpha4-integrin in neutrophil chemotaxis. Journal of Cell Science 2005, 118(November (Pt 22)):5205-5220.
173. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annual Review of Immunology 2007, 25:619-647.
174. Schymeinsky J., Sperandio M., Walzog B. The mammalian actin-binding protein 1 (mabp1): a novel molecular player in leukocyte biology. Trends in Cell Biology 2011, 21(April (4)):247-255.
175. Suzuki M., Asako H., Kubes P., Jennings S., Grisham M.B., Granger D.N. Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvascular Research 1991, 42(September (2)):125-138.
176. Diamond M.S., Staunton D.E., Marlin S.D., Springer T.A. Binding of the integrin mac-1 (cd11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991, 65(June (6)):961-971.
177. Javaid K., Rahman A., Anwar K.N., Frey R.S., Minshall R.D., Malik A.B. Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase czeta-dependent activation of intercellular adhesion molecule-1. Circulation Research 2003, 92(May (10)):1089-1097.
178. Wójciak-Stothard B., Williams L., Ridley A.J. Monocyte adhesion and spreading on human endothelial cells is dependent on rho-regulated receptor clustering. The Journal of Cell Biology 1999, 145(June (6)):1293-1307.
179. Fan J., Frey R.S., Rahman A., Malik A.B. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-alpha-induced nf-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. The Journal of Biological Chemistry 2002, 277(February (5)):3404-3411.
180. Chen X.L., Zhang Q., Zhao R., Ding X., Tummala P.E., Medford R.M. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells. The Journal of Pharmacology and Experimental Therapeutics 2003, 305(May (2)):573-580.
181. Nourshargh S., Hordijk P.L., Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nature Reviews: Molecular Cell Biology 2010, 11(May (5)):366-378.
182. Khandoga A., Huettinger S., Khandoga A.G., Li H., Butz S., Jauch K.W., et al. Leukocyte transmigration in inflamed liver: a role for endothelial cell-selective adhesion molecule. Journal of Hepatology 2009, 50(April (4)):755-765.
183. Weber C., Fraemohs L., Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nature Reviews: Immunology 2007, 7(June (6)):467-477.
184. Khandoga A., Kessler J.S., Meissner H., Hanschen M., Corada M., Motoike T., et al. Junctional adhesion molecule-a deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 2005, 106(July (2)):725-733.
185. Goel R., Boylan B., Gruman L., Newman P.J., North P.E., Newman D.K. The proinflammatory phenotype of pecam-1-deficient mice results in atherogenic diet-induced steatohepatitis. American Journal of Physiology: Gastrointestinal and Liver Physiology 2007, 293(December (6)):G1205-G1214.